Literature DB >> 16263054

Post-infectious encephalomyelitis.

Cornelia Mihai1, Burk Jubelt.   

Abstract

The term post-infectious encephalomyelitis (PIEM) is frequently used interchangeably with acute disseminated encephalomyelitis (ADEM), although technically PIEM occurs after a known infection whereas with ADEM there is no antecedent infection. PIEM represents one of the primary demyelinating disorders of the central nervous system, along with multiple sclerosis and Devic's disease. There is no specific diagnostic test for any of these conditions and at onset it may be difficult to differentiate between ADEM and the first attack of multiple sclerosis. However, there are clinical and magnetic resonance imaging features that allow differentiation between PIEM/ADEM and a relapsing disease such as multiple sclerosis. Some patients improve spontaneously; most improve with methylprednisolone. If that fails, plasma exchange or intravenous immunoglobulin may be effective.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16263054     DOI: 10.1007/s11910-005-0031-2

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   6.030


  52 in total

1.  Acute disseminated encephalomyelitis as manifestation of primary HIV infection.

Authors:  P Narciso; S Galgani; B Del Grosso; M De Marco; A De Santis; P Balestra; V Ciapparoni; V Tozzi
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

2.  Plasmapheresis in fulminant acute disseminated encephalomyelitis.

Authors:  R Miyazawa; A Hikima; Y Takano; H Arakawa; T Tomomasa; A Morikawa
Journal:  Brain Dev       Date:  2001-10       Impact factor: 1.961

3.  Survey of herpes simplex virus infections of the central nervous system, including acute disseminated encephalomyelitis, in the Kyushu and Okinawa regions of Japan.

Authors:  M Kaji; T Kusuhara; M Ayabe; H Hino; H Shoji; T Nagao
Journal:  Mult Scler       Date:  1996-09       Impact factor: 6.312

Review 4.  Can New Zealand eliminate measles?

Authors:  O Mansoor; G Durham; M Tobias
Journal:  N Z Med J       Date:  1997-10-24

5.  Plasmapheresis in fulminant acute disseminated encephalomyelitis.

Authors:  D S Kanter; D Horensky; R A Sperling; J D Kaplan; M E Malachowski; W H Churchill
Journal:  Neurology       Date:  1995-04       Impact factor: 9.910

6.  MRI of acute disseminated encephalomyelitis after coxsackie B infection.

Authors:  P David; D Baleriaux; W O Bank; D Amrom; D De Temmerman; C Babusiaux; C Matos; C Van Steenwinckel; C Lloret-Pastor; H B Szliwowski
Journal:  J Neuroradiol       Date:  1993-12       Impact factor: 3.447

7.  Encephalomyelitis subsequent to mycoplasma infection with elevated serum anti-Gal C antibody.

Authors:  S Kumada; H Kusaka; M Okaniwa; O Kobayashi; S Kusunoki
Journal:  Pediatr Neurol       Date:  1997-04       Impact factor: 3.372

8.  MRI in acute disseminated encephalomyelitis following Semple antirabies vaccine.

Authors:  J M Murthy
Journal:  Neuroradiology       Date:  1998-07       Impact factor: 2.804

9.  Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis.

Authors:  E Marchioni; K Marinou-Aktipi; C Uggetti; M Bottanelli; A Pichiecchio; D Soragna; F Imbesi; A Romani; M Ceroni
Journal:  J Neurol       Date:  2002-01       Impact factor: 4.849

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  7 in total

Review 1.  Molecular and cellular immune mediators of neuroprotection.

Authors:  Nicolas P Turrin; Serge Rivest
Journal:  Mol Neurobiol       Date:  2006-12       Impact factor: 5.590

Review 2.  [Inflammatory diseases of the spinal column and the myelon].

Authors:  F J Ahlhelm; J M Lieb; S Ulmer; T Sprenger; C Stippich; J Kelm
Journal:  Radiologe       Date:  2011-09       Impact factor: 0.635

3.  [Spinal infections].

Authors:  I Grunwald; P Papanagiotou; M Politi; C Roth; M Backens; F Ahlhelm; W Reith
Journal:  Radiologe       Date:  2006-12       Impact factor: 0.635

4.  Role of Plasma Exchange in a Steroid- and IVIG-Refractory Patient with Acute Disseminated Encephalomyelitis: A Case Report.

Authors:  Parmatma Prasad Tripathi; Rekha Hans; Ratti Ram Sharma; Divjot Singh Lamba; Preeti Paul; Naveen Sankhyan; Chandana Bhagwat; Paramjeet Singh
Journal:  Transfus Med Hemother       Date:  2020-02-20       Impact factor: 3.747

Review 5.  Post-malaria neurological syndrome: four cases, review of the literature and clarification of the nosological framework.

Authors:  Yanis Tamzali; Sophie Demeret; Elie Haddad; Hélène Guillot; Eric Caumes; Stéphane Jauréguiberry
Journal:  Malar J       Date:  2018-10-26       Impact factor: 2.979

6.  Acute disseminated encephalomyelitis.

Authors:  James J Sejvar
Journal:  Curr Infect Dis Rep       Date:  2008-07       Impact factor: 3.663

Review 7.  Acute disseminated encephalomyelitis: clinical and pathogenesis features.

Authors:  Farshid Noorbakhsh; Richard T Johnson; Derek Emery; Christopher Power
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.